Our subsidiaries

Sosei R&D Ltd.

Capital JPY 182,737,452
Scope of business Licensing and business development outside Japan
Representative Director Shinichi Tamura
Holding company stake 100%
Address 2nd Floor, London BioScience Innovation Centre
2 Royal College Street London NW1 0NH, United Kingdom (map)
Tel: +44-(0)20-7691-2081
Fax: +44-(0)20-7209-2484

Heptares Therapeutics Ltd.

Capital JPY 45,525,238
Scope of business Drug discovery based on targeting of G protein-coupled receptors
Representative Director, CEO Malcolm Weir, CEO
Holding company stake 100%
Address BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire, AL7 3AX, UK (map)
URL www.heptares.com

Jitsubo Co. Ltd.

Capital JPY 100,000,000
Scope of business Development of peptide drugs, licensing of peptide API manufacturing technology
Representative Director Teruaki Tsukamoto(Chief Executive Officer)
Kazuaki Kanai(Senior V.P., Research and Development)
Holding company stake 43.7%
Address Life Science Research Center 4-1
1-1-43 Suehiro-cho, Tsurumi, Yokohama 230-0045, Japan
URL www.jitsubo.com/en/

Sosei Co. Ltd.

Capital JPY 250,000,000
Scope of business Drug development and sales, business development in Japan
Representative Director Tadayoshi Yasui
Holding company stake 100% (voting rights)
Address PMO Hanzomon 11F
2-1 Kojimachi, Chiyoda-ku
Tokyo 102-0083 Japan (map)
Tel: +81-(0)3-5210-3290 (general enquiries)
Fax: +81-(0)3-5210-3291

Sosei CVC Ltd.

Capital JPY 10,000,000
Scope of business Managing Sosei RMF1 (Regenerative Medicine Fund)
Representative Director Peter Bains
Holding company stake 90%
Address PMO Hanzomon 11F
2-1 Kojimachi, Chiyoda-ku
Tokyo 102-0083 Japan (map)
Tel: +81-(0)3-5210-3290 (general enquiries)
Fax: +81-(0)3-5210-3291